METHODS Special Issue: Clinical and Analytical Performance Data for NxTAG RPP

Highly scalable, multiplex molecular assay is comparable to xTAG RVP performance If you’ve ever used an assay based on xTAG® Technology, you may wonder how the newer NxTAG® Chemistry stacks up. A new publication in Methods uses clinical and analytical data from respiratory pathogen panels to demonstrate how both performance and workflow have improved with […]

Read More…

Custom Assays: ‘If You Dream It, We Can Multiplex It’

Video presentation details assay development services from MilliporeSigma With new biomarkers being published every day, fewer and fewer scientists can get exactly what they need from an off-the-shelf immunoassay kit. That’s why MilliporeSigma offers extensive custom xMAP® Technology assay design and development services, which are showcased in this 10-minute video presentation from Mike Godeny, Head […]

Read More…

Webinar: Protein Conformational Analysis Goes High-Throughput with xMAP Technology

Technique provides critical data for development of monoclonal antibodies and biosimilars At a 2018 xMAP® Connect user group meeting, Xing Wang, President of Array Bridge, spoke about how his team is using xMAP Technology to streamline the development of new biologics and biosimilars for pharma/biotech scientists. The 30-minute presentation focuses on protein conformational analysis (PCA), […]

Read More…

Now Available: Custom Assay Services from Luminex

From full development to providing guidance, we can help you get to a functional assay—faster. The Luminex team is pleased to announce the launch of our custom development service, LuminexPLORE Lab, for assays based on xMAP® Technology. For more than 20 years, we have collaborated with customers and partners around the world in designing and […]

Read More…

METHODS Special Issue: Modifying the Luminex Workflow for Hazardous Pathogen Research

New protocol allows scientists to create assays in containment labs and perform analysis elsewhere Scientists in the UK have developed a new protocol that utilizes Luminex multiplex assays even in specialized laboratories where space for instruments is limited. A recent hazardous pathogen study has broad implications for any research team, especially those facing space limitations. […]

Read More…

Patient Perspective: How Precision Oncology Makes a Difference

Interview shows why clinical routine and advanced science need to work together It’s not often we get to hear the patient perspective, which makes this recent Mendelspod interview featuring a researcher and the husband of the cancer patient he’s helping particularly compelling. The 30-minute podcast features Christian Regenbrecht, CEO of Berlin-based CELLphenomics GmbH (better known […]

Read More…

Webinar: ‘The Devil Is in the Diluents’

How to manage interference in immunoassays with careful design choices Interference is a non-trivial concern when designing multiplex immunoassays, but it can be managed with careful attention to potential problems. That’s the gist of a brief video presentation from Richard Fuerstenberg, senior commercial application scientist at R&D Systems. The presentation begins with a look at […]

Read More…

Five-Minute Master Class: Design Practices for xMAP® Assays

Bio-Rad expert shares SMARTS design principles for optimizing multiplex immunoassays Ever wondered how the pros handle design for xMAP® Technology assays? This five-minute video presentation from Bio-Rad’s Amy Hendricksen offers a fast, fun look at the core design principles that are important to any multiplex immunoassay. Bio-Rad was the first Luminex partner and has been […]

Read More…

In a Debate About Mitosis, New Study Links Process to Cell Size

Amnis® ImageStream®X Mk II imaging flow cytometry helps answer a longstanding question about what triggers cell mitosis It has been more than 140 years since the discovery of the mitosis process, but until now, scientists were hard-pressed to explain what triggers cell division. The most common hypotheses have speculated that cells divide when they reach […]

Read More…

Meet Ankit Patel, QuantiGene™ Assay Developer at Thermo Fisher Scientific

Plus: 6 tips for QuantiGene assays When you want an assay that can detect nucleic acids, you’ll likely choose the high-quality Invitrogen™ ProcartaPlex™ and QuantiGene™ Plex assays from Thermo Fisher Scientific, a Luminex partner. The QuantiGene assay uses branched DNA (bDNA) technology, relying on signal amplification instead of target amplification for optimal quantitation of transcripts. […]

Read More…